MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 915-920

  Dong, Mei ^a   Yang, Piyong ^b   Hua, Fang ^c  

^a The People s Hospital of Zoucheng   (China)

^b BINZHOU PEOPLE S HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Endometriosis; MicroRNAs; Ovarian neoplasms

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 191; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; MIRN191 MICRORNA, HUMAN; TIMP3 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL TRANSFORMATION; COMPLICATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR INVASION;

ADULT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84925939842     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893872     Document Type: Article

References (15)

1. Giudice LC, Kao LC: Endometriosis. Lancet, 2004; 364: 1789–99
2. Cho HY, Kim K, Jeon YT et al: CA19-9 elevation in ovarian mature cystic ter-atoma: discrimination from ovarian cancer – CA19-9 level in teratoma. Med Sci Monit, 2013; 19: 230–35
3. Pearce CL, Templeman C, Rossing MA et al: Ovarian Cancer Association, Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol, 2012; 13: 385–94
4. Braza-Boils A, Mari-Alexandre J, Gilabert J et al: MicroRNA expression pro-file in endometriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod, 2014; 29: 978–88
5. Suryawanshi S, Vlad AM, Lin HM et al: Plasma microRNAs as novel bio-markers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res, 2013; 19: 1213–24
6. Teague EM, Print CG, Hull ML: The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update, 2010; 16: 142–65
7. Panda H, Pelakh L, Chuang TD et al: Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKbeta, KLF9, and FBLN5. Reprod Sci, 2012; 19: 786–96
8. Kashiwagi M, Tortorella M, Nagase H, Brew K: TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5), J Biol Chem, 2001; 276: 12501–4
9. Qin S, Zhu Y, Ai F et al: MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. Neoplasma, 2014; 61: 27–34
10. Panda H, Chuang TD, Luo X, Chegini N: Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3. J Clin Endocrinol Metab, 2012; 97: E1316–26
11. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell, 2009; 136: 215–33
12. Nagpal N, Kulshreshtha R: miR-191: an emerging player in disease biology. Front Genet, 2014; 5: 99
13. Catasus L, Pons C, Munoz J et al: Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas. Histopathology, 2013; 62: 632–41
14. Guan Z, Zhang J, Song S, Dai D: Promoter methylation and expression of TIMP3 gene in gastric cancer. Diagn Pathol, 2013; 8: 110
15. Lee J, Banu SK, Subbarao T et al: Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endome-triotic epithelial and stromal cells through suppression of metalloprotein-ases. Mol Cell Endocrinol, 2011; 332: 306–13